Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing
Nagarathinam Selvaraj(Indiana University Bloomington), Ramarao Vepachedu(Frederick National Laboratory for Cancer Research), Asaf Alimardanov(DSM (Netherlands)), Brian Bowser(Frederick National Laboratory for Cancer Research), Diane Golebiowski(University of Massachusetts Chan Medical School), Peter Pecháň(Solidus Biosciences (United States)), Jenna Burns(Frederick National Laboratory for Cancer Research), Chao-Kuei Wang(Frederick National Laboratory for Cancer Research), Trevor Broadt(Frederick National Laboratory for Cancer Research), Nirmala Saptharishi(Frederick National Laboratory for Cancer Research), George Mitra(Frederick National Laboratory for Cancer Research), N. Nora Yang(National Center for Advancing Translational Sciences)
Cited by 26
Related Papers
Use of “Homeopathic” Ligand‐Free Palladium as Catalyst for Aryl‐Aryl Coupling Reactions
|Advanced Synthesis & Catalysis|2004|205
The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma
|Cancer Cell|2011|156
Requirement of the ATM/p53 Tumor Suppressor Pathway for Glucose Homeostasis
|Molecular and Cellular Biology|2010|118
Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation
|Journal of Lipid Research|2018|109